A client comes to the clinic complaining of dysphagia and states that "he feels like food is stuck in his throat." The physician suspects esophageal cancer. Which of the following is a risk factor for esophageal cancer?

A. Epigastric discomfort is a common symptom of peptic ulcer disease, but it is not the priority finding. This symptom is usually manageable with appropriate treatment, such as antacids or proton pump inhibitors.
B. Hematemesis (vomiting blood) is a critical finding and indicates active bleeding, which can be life-threatening. This requires immediate attention as it suggests a potential complication, such as ulcer perforation or severe gastric bleeding, that can lead to hypovolemic shock. It is the priority finding because it indicates the need for urgent medical intervention.
C. Constipation is not a priority concern in a patient with peptic ulcer disease unless it is severe and related to medication (such as opioids). While it may be uncomfortable, it does not pose the immediate risk that hematemesis does.
D. Dyspepsia, or indigestion, is another common symptom of peptic ulcer disease. While it can be bothersome, it does not represent an acute, life-threatening issue like hematemesis does.

A. Cytotec does not enhance the pain-relieving effects of NSAIDs. Instead, it works to protect the stomach lining from the harmful effects of NSAIDs, which can cause gastrointestinal ulcers and bleeding.
B. Misoprostol (Cytotec) is used to protect the stomach lining from damage caused by NSAIDs, which can increase the production of stomach acid and decrease the protective mucus lining. Cytotec helps prevent gastric ulcers and other GI complications associated with long-term NSAID use.
C. Cytotec does not directly decrease inflammation in the joints. NSAIDs are the primary medications for reducing joint inflammation in conditions like arthritis.
D. Cytotec does not reduce the risk of developing blood clots from NSAIDs. It is primarily used for its protective effect on the gastrointestinal system.